Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling full on Mounjaro is one of the most commonly reported experiences in the first weeks of treatment, and it happens for a straightforward biological reason. Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, that together slow how quickly food leaves your stomach and signal to the brain that you've eaten enough — often well before you'd normally stop. For most people this reduced appetite is the intended effect, not a side effect to worry about. That said, eating too little (or the wrong things) while on treatment can leave you tired and underweight on muscle rather than fat, so understanding what fullness on Mounjaro actually means matters. These are prescription-only medicines; a GPhC-registered prescriber assesses whether tirzepatide is appropriate for you before any treatment begins, as the NHS tirzepatide guidance makes clear.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The sensation starts in the stomach. Tirzepatide slows gastric emptying, meaning food sits in your stomach longer than it would otherwise. This is not a glitch, it is one of the central mechanisms by which the medicine works. Your brain also receives direct GIP and GLP-1 signals that reduce appetite hormones and increase satiety hormones, so the fullness you feel has two independent sources: physical (food moving slowly) and hormonal (your appetite thermostat turned down).
This dual action is what distinguishes tirzepatide from older single-pathway GLP-1 medicines. You can read more about the pharmacology on our tirzepatide overview. The practical upshot is that a portion you'd normally finish in ten minutes can feel like a full meal after three bites. That's not psychological; it's physiology.
The fullness is usually most pronounced shortly after starting treatment at 2.5mg and after each dose increase. Many people find it settles into something easier to manage after two to three weeks at any given dose. If it doesn't settle, that's worth raising with your prescriber, not just tolerating.
The instinct when you feel full quickly is to skip the next meal. Resist it. Consistent under-eating on tirzepatide accelerates muscle loss alongside fat loss, and inadequate nutrition can leave you feeling weak and fatigued, something a separate guide covers in more depth. The goal is to eat less, but eat deliberately.
Practical adjustments most people find useful: smaller plates, slower eating, stopping at the first natural pause rather than pushing through. Protein at every meal is not optional, it's the nutrient that preserves muscle when overall intake is low. Aim to eat your protein portion first, then vegetables, then anything else. If you manage only a small amount, at least the most important macronutrient came first.
Hydration matters too. The sensation of fullness can blur with mild dehydration, and some people inadvertently cut fluids alongside food. Keep water within reach throughout the day, not during the meal itself, where liquid can amplify the full feeling. A small practical tip: some people find it easier to eat their main meal mid-morning, when appetite tends to be slightly higher than in the evening, rather than forcing a large dinner when fullness peaks.
There is a difference between eating less and not eating. Nausea, vomiting and persistent stomach discomfort are common in the early weeks, the Mounjaro side effects guide covers the GI picture in full. If fullness is so severe that you cannot keep fluids down for more than a day, or if you're losing weight at an alarming rate and feel consistently unwell, contact a healthcare professional promptly. Severe, persistent stomach pain that extends to the back is a separate concern and requires urgent medical assessment, the MHRA Yellow Card scheme is where suspected serious side effects can be reported.
Less urgently but still worth flagging: if the fullness is causing you to consistently eat fewer than around 800 calories for more than a few days, discuss it with your prescriber. A dose pause or slower titration is sometimes the right call. Treatment should be working with your life, not making it harder.
For the majority of people, the intense early fullness softens over time. Appetite does not disappear entirely, it recalibrates. Most people on maintenance doses describe eating smaller meals comfortably rather than feeling unable to eat at all. If you find yourself somewhere in the middle (less hungry than before, but not miserable about food) that is the intended state.
The detailed page on satiety and Mounjaro explores how the effect evolves across the titration schedule. For cost context on treatment, the Mounjaro prices page sets out what private treatment typically involves. And if you notice other physical sensations alongside fullness (feeling cold or feeling hot are both reported) those pages explain what's likely behind them.
Clinical oversight throughout makes a meaningful difference here. At nume, a named GPhC-registered prescriber reviews your case before every repeat, not just at the start. Questions about how you're tolerating the medicine, including persistent fullness, are part of that conversation. If you haven't yet started treatment, start your free consultation to find out whether tirzepatide is appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.